Millie
your market intelligence analyst
Search Results
75 results
Your search is now limited to «Genentech» expert search.
As we previously reported, on July 10, 2019, Genentech filed motions for a temporary restraining order and preliminary injunction against Amgen in the Genentech v.
More from Goodwin Procter BioSimilars Blog:
Contract Pharma 07/17/2019 11:32
Breaking News Aims to treat patients with neurological disorders such as multiple sclerosis 07.17.19 Convelo Therapeutics, Inc. has entered into an exclusive worldwide collaboration with Genentech to accelerate discovery and development of novel remyelinating medicines for neurological disorders such as multiple sclerosis (MS.
More from Contract Pharma:
PR Newswire 07/17/2019 05:38
Skyhawk wird auf Basis seiner SkySTARTM-Plattform Medikamentenkandidaten entwickeln, die sich gegen mehrere Targets bei onkologischen und neurodegenerativen Erkrankungen richten. Im Gegenzug erhält Skyhawk eine Vorauszahlung mit Aussicht auf langfristige Erlöse von mehr als 2 Mrd. $,...
More from PR Newswire:
Reuters.com 07/16/2019 11:32
(Corrects headline to "Convelo Therapeutics Enters Worldwide Collaboration with Genentech" from "Convelo Therapeutics to Acquire Genentech". Also corrects source to "Convelo Therapeutics" from "Roche Holding AG")
More from Reuters.com:
ENDPOINTS 07/16/2019 09:56
After announcing tie-ups with Sosei Heptares and Skyhawk on Tuesday, Genentech unveiled yet another deal: with Cleveland-based biotech Convelo Therapeutics.
More from ENDPOINTS:
FierceBiotech 07/16/2019 09:38
Genentech started Tuesday with a $1 billion biobucks deal with GPCR specialist Sosei Heptares and before the morning was out followed it with two more: one focused on cancer and neurodegenerative diseases with Skyhawk Therapeutics and ...
More from FierceBiotech:
Business Wire 07/16/2019 08:30
Convelo and Genentech will collaborate to discover novel remyelination therapies for MS and other myelin disorders.
More from Business Wire:
PharmiWeb.com 07/16/2019 02:30
Under the terms of the agreement, the collaboration will combine the proprietary GPCR-focused structure-based drug design capabilities at Sosei Heptares with Genentech's discovery, development and therapeutic area expertise directed towards multiple GPCR targets nominated by Genentech.
More from PharmiWeb.com:
Company Drug/Device Medical Condition Status Terns Pharmaceuticals, Inc. TERN-101 non-alcoholic steatohepatitis (NASH) Phase I trial initiated OnKure, Inc. OKI-179 advanced solid tumors Phase I trial initiated Purdue Pharma, L.P. nalmefene hydrochloride (HCl) opioid overdose Phase I trial initiated Goldfinch Bio, Inc. GFB-887 kidney disease Phase I trial initiated Aerpio Pharmaceuticals, Inc. AKB-9778 primary open angle [...]
More from CenterWatch Clinical Trials Today Headlines:

Therapeutic Areas

Clinical Trials and Phases

Business Issues

Companies - Public

Companies - Venture Funded

Financial Results

Global Markets

Global Risk Factors

Government Agencies

Job Titles

Legal and Regulatory

Cell Receptors

Cells

Diagnostics and Therapeutics

Diseases

Drugs - Brand Names

Drugs - Generic

Enzymes

Genes

Health Care

Health and Wellness

Human Anatomy

Mechanisms of Action

Medical Devices

Proteins

Sources

Strategic Scenarios

Trends

Hints:

On this page, you see the results of the search you have run.  You may also view the following:

  •  Click on this drop-down menu on the right hand side of the page, to choose between the machine learning-produced Insights Reports, or the listing of concepts extracted from the results, in chart or list format. 


  •  View the number of search results returned for the search in each of your collections, and click on any of those numbers to view the entire listing of results from the chosen collection.

  •  Use the search adjustment drop-downs to change the scope, sorting, and presentation of your results.

  •  Show or hide the record’s caption (content description).

  •  Show actions that can be made with the search result record.

  •  Click on the Save button after running your search, to save it so that its results will be updated each time relevant new content is added to the designated collection. You may choose to be notified via search alerts.

Click here for more info on Search Results

Click here for more info on Machine Learning applications